Periodontitis and Inflammation: Study on Biological Samples

NCT ID: NCT06012019

Last Updated: 2025-08-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-30

Study Completion Date

2028-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Periodontitis is a major public health problem because it is widespread in the adult population. It leads to the irreversible destruction of the anchoring tissues of the teeth, and represents a modifiable risk factor for systemic inflammatory pathologies. This chronic inflammatory disease, which is associated with oral dysbiosis involving Porphyromonas gingivalis, is triggered by a permissive immune response. It is preceded by a reversible clinical phase, during which there is no bone resorption process: gingivitis. The understanding of the key mechanisms involved in the evolution from gingivitis to periodontitis, which will allow to early identify patient at risk of periodontitis, remain unclear at this time.

Neutrophils are the main cells of inflammation present within the periodontal pockets. The excess of certain neutrophils or the alteration of their functions is associated with the triggering of periodontitis, whereas their activity, finely orchestrated, would be a key to periodontal homeostasis. It is likely that some periodontal bacteria, including P. gingivalis, but also products of matrix catabolism could deregulate the physiological functions of neutrophils towards pro-inflammatory and catabolic profiles. Moreover, to date, the differentiation and role of neutrophil subsets in periodontal homeostasis as well as in gingivitis and its evolution into periodontitis remain poorly studied.

The investigators hypothesize that various subsets of neutrophils may play different roles during the development of periodontitis (evolution of gingivitis to periodontitis).

The primary objective is to characterize neutrophil subtypes associated with periodontal destruction during periodontitis.

Secondary objectives are :

1. Identify specific interactions of tissue-activated neutrophils with the matrix microenvironment during periodontitis
2. Identify specific interactions of tissue or oral (salivary) activated neutrophils with the oral microbiota during periodontitis
3. Identify specific oral (salivary) neutrophil subtypes in periodontal health, gingivitis and periodontitis
4. Evaluate the function, including pro-osteoclastogenic function, of oral neutrophils compared to blood neutrophils stimulated by infection

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It's a cross-sectional, monocenter prospective, open-label, non randomized case control study to collect tissue, crevicular, salivary, and serum samples as part of the patient's routine care in oral medicine departments to form a biological collection. The samples and the clinical data of the patients.

Patients will be recruited in the oral medicine departments of AP-HP Charles Foix hospital (Ivry/seine) by periodontists in three groups (Cases : Group 1 : Gingivitis, Group 2 : Periodontitis, and Controls = healthy periodontium. All patients will require surgical care).

The time-line of the research is consistent with the usual patient management in oral medicine departments. Inclusion period is 36 months. There is no specific follow-up due to the research. Gingival tissue sampling during surgery of patients will be performed after their inclusion.

Assessment Criteria :

1. Neutrophil subtypes analysis based on co-expression of neutrophil function markers from a panel of 24 markers by imaging on sections.
2. Identification by immunohistofluorescence (on tissues) of the expression of matrix proteins described as regulating neutrophil function, and search of co-location between these proteins and certain neutrophil subtypes.
3. Identification by immunohistofluorescence (on tissue) of key bacteria of oral dysbiosis in periodontitis, and search for co-localization between these bacteria and certain neutrophil subtypes.
4. Assessment of neutrophil sub-types present in the patient's saliva and study of the correlation within tissue neutrophils during periodontal health, gingivitis and periodontitis.
5. Differentiation and activity of osteoclasts in co-culture with isolated oral /blood neutrophils in patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Periodontitis Cases

Patients with stage 3 or 4 periodontitis (Chicago 2017) ; BOP ≥ 10%, PD≥ 4mm Patients requiring surgical care such as dental avulsion or pre-prosthetic periodontal surgeries

Biological sampling in Periodontitis Case

Intervention Type OTHER

Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;

J+7 : tooth extraction : gingival explant sampling

J+15 : Healing control

Gingivitis Cases

BOP ≥ 10%, PD≤ 3mm according to Chicago 2017 Patients requiring surgical care such as dental avulsion or pre-prosthetic periodontal surgeries

Biological sampling in Gingivitis Case

Intervention Type OTHER

Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;

J+7 : tooth extraction or pre-prosthetic periodontal surgeries : gingival explant sampling

J+15 : Healing control

Control

BOP \< 10%, PD≤ 3mm Patients with gingival health on intact or reduced periodontium without a history of periodontitis and requiring surgical care such as dental avulsion or aesthetic surgeries

Biological sampling in Control Case

Intervention Type OTHER

Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;

J+7 : tooth extraction or pre-prosthetic periodontal surgeries : gingival explant sampling

J+15 : Healing control

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biological sampling in Periodontitis Case

Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;

J+7 : tooth extraction : gingival explant sampling

J+15 : Healing control

Intervention Type OTHER

Biological sampling in Gingivitis Case

Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;

J+7 : tooth extraction or pre-prosthetic periodontal surgeries : gingival explant sampling

J+15 : Healing control

Intervention Type OTHER

Biological sampling in Control Case

Periodontal bacteria, gingival fluid, unstimulated saliva and blood collection;

J+7 : tooth extraction or pre-prosthetic periodontal surgeries : gingival explant sampling

J+15 : Healing control

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Common criteria for all patient groups

* Patient \> 18 years old
* Patient affiliated to a national health insurance
* Patient who speaks and understands French well enough to be able to read and understand the study information note.
* Patient who does not object to his participation in the study

Specific Criteria :

* Control Group = BOP \< 10%, PI\<20%, PD≤ 3mm
* Gingivitis cases = BOP ≥ 10%, PD≤ 3mm
* Periodontitis cases = BOP ≥ 10%, PD\> 3mm

Exclusion Criteria

* Patients who have received antibiotic prophylaxis, antibiotic therapy, or anti-inflammatory treatment within 3 months prior to inclusion
* Pregnant or breastfeeding women
* Patients suffering from a disease with defective neutrophil number, activity, activation or function
* Patient deprived of liberty by judicial or administrative decision.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marjolaine Gosset, PU-PH

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charles-Foix Hospital

Ivry-sur-Seine, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marjolaine Gosset, PU-PH

Role: CONTACT

01 49 59 48 11

François Ferré, MCU-PH

Role: CONTACT

01 49 59 48 11

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marjolaine Gosset, PU-PH

Role: primary

01 49 59 48 11

Sandrine Dos Santos

Role: backup

01 49 59 48 11

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP230385

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Haemochromatosis and Periodontitis
NCT04006249 COMPLETED NA